NFCR believes that the best path to ending cancer in our lifetime is to invest heavily in high-risk/high-reward research that will yield long-term impacts in patient outcomes. Other organizations have done an outstanding job bringing awareness to the public, now is the time to act and move forward towards a cure! Read Our Financials & 990

Research & Education




$25-$100 – Stains one tissue slide from a tumor biopsy to look for a predictive biomarker of cancer metastasis

$100  –  Performs one biopsy to get tumor tissues from a patient for a variety of pathological tests and biological analyses

$250 – Buys one case of petri dishes for growing cancer cells – an essential first step to identify tumor markers or test treatment effectiveness of new drugs

$500-750 – Buys one antibody test to determine whether tumor cells have a specific marker for drug resistance

$1,000 – Carries out a comprehensive genome-wide analysis on all genes in one tumor sample, for developing targeted and personalized cancer therapies

NFCR has been evaluated by Charity Navigator, the world’s largest and most trusted nonprofit evaluator, and earned a Four-Star Rating! This is the highest possible rating on Charity Navigator.

We are committed to the pursuit of CURES for ALL cancers. As we celebrate the milestone of 50 years of making breakthroughs happen in cancer research, we are inspired by this recognition of our integrity and ability to make the next 50 years of cures possible.

charity navigator 4 star
WiseGivng Donor Handbook
Click to Read

NFCR is proud to be a trusted steward of our supporters’ philanthropic gifts.

We are an accredited charity, as reviewed by the Better Business Bureau. Read more in the BBB’s latest WiseGiving Donor Handbook.